NVS

Novartis AG

NVS·NYSE

FollowCompareShare

143.75+0.64 (+0.45%)today

At close: Oct 9, 4:00 PM EDT · Real-time · USD

After hours143.75−0.01 (−0.01%)Oct 9, 4:13 PM EDT

1D5D1M6MYTD1Y5YMAX

MountainLineCandles

Indicators

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close143.11

Open142.92

Day range142.80143.96

52-week range121.57170.46

Volume1.90M

Avg. volume (3M)1.96M

Market cap273.23B

P/E ratio (TTM)21.71

Forward P/E14.67

EPS (TTM)6.62

Dividend yield3.30% (4.74)

Beta (5Y)—

Shares outstanding1.90B

Earnings dateOct 27, 2026

Analyst target—

Profit margin—

Latest news

All NVS news ›

Yahoo Finance·7h ago

Arcus Biosciences, Inc. (RCUS)

Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Arcus Biosciences, Inc. (RCUS) Arcus Biosciences, Inc. Overview Biotechnology / Healthcare Arcus Biosciences, Inc., a clinical-stage biopharmaceutical…

Yahoo Finance·7h ago

Hikma Pharmaceuticals PLC (HIK.L)

stock price, news, quote and history Yahoo Finance UK Hikma Pharmaceuticals PLC (HIK.L) Hikma Pharmaceuticals PLC Overview Drug Manufacturers - Specialty & Generic / Healthcare Hikma Pharmaceuticals PLC develops, manufactures, markets, and…

The Globe and Mail·8h agoDownbeat

MedinCell Halts Euronext Trading Ahead of Market-Sensitive Announcement

An update from MedinCell SA ( (FR:MEDCL) ) is now available. MedinCell SA requested and obtained a temporary suspension of trading in its shares on Euronext Paris from 9:00 a.m. CEST, ahead of a scheduled company announcement, with trading…

Yahoo Finance·11h ago

Corcept Therapeutics Inc (HTD.DU) Stock Forum & Discussion

Yahoo! Finance Canada Oops, something went wrong Corcept Therapeutics Inc (HTD.DU) - NVLH.NE NEVADA LITHIUM RESOURCES INC 0.0400 -0.0350 (-46.67%) - BULL.CN Quest Critical Metals Inc. 0.0150 -0.0050 (-25.00%) - NVLH.V Nevada Lithium…

Yahoo Finance·11h ago

AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie Up

AstraZeneca (LSE:AZN) has launched a new AI-driven biologics discovery collaboration with Carterra, announced ahead of trading on 9 October 2026. The project focuses on large molecule biologics, aiming to shorten experimental decision…

Fortune·13h ago

What a desert lizard teaches us about patents and the GLP-1 revolution

Dr. Eng patented the peptide. Amylin Pharmaceuticals eventually licensed and developed it into the first GLP-1 medicine. In 2005, the FDA approved it to treat type 2 diabetes. That 15-year journey — from discovery to drug approval —…

Seeking Alpha·16h agoDownbeat

Entrada Therapeutics: Weak Dystrophin Data May Be Creating A Buying Opportunity

Entrada Therapeutics (ENTR) Buy call: $8.50 fair value (~52% upside). Valuation is anchored by risk-adjusted pipeline estimates. See more details here. - Entrada Therapeutics is rated Buy with a $8.50 fair value, offering ~52% upside from…

Yahoo Finance·18h agoUpbeat

Damora Therapeutics (DMRA) Climbed, So What Is Drawing Attention Now?

Damora Therapeutics (DMRA) traded at $21.08 at the last close, drawing fresh attention to how this biopharmaceutical player's hematology pipeline and financial profile intersect for long term investors. Scan how Damora Therapeutics…

Yahoo Finance·19h ago

Why Enliven Therapeutics' (ELVN) ENABLE-2 Trial Design Raises New Questions About Its CML Strategy

This progress clarifies the registrational pathway for Enliven's lead BCR::ABL1 inhibitor, including a statistically powered plan to show at least a 10‑percentage‑point improvement in major molecular response by Week 24 over current…

Yahoo Finance·1d ago

PolyPeptide Group (SWX:PPGN) Looks Fully Valued Following Samsung Biologics Tender Offer

UBS cut its rating on PolyPeptide Group (SWX:PPGN) to neutral after Samsung Biologics launched an all cash tender offer, shifting investor attention toward deal completion rather than potential new upside. At a share price of CHF43.85,…

From articles in the 4Search news index.

In the news

3,058mentions in 30 days

Upbeatheadline tone

Mentioned with

Eli Lilly1,567Pfizer1,286Astrazeneca1,231Novo Nordisk1,043Google930Bristol Myers Squibb765Johnson & Johnson685U.S. Food and Drug Administration463

People in the coverage

Donald Trump461Moderna434Kim Johansen345Sarita Garza337Basaglar331Danessa Lincoln318

Themes

Pharma1,026Biotech961Health687Pharmaceuticals684Biotechnology651Healthcare600Type-Newspost451Drug Development445

Most coverage from

1. marketscreener.com235
2. tradingview.com188
3. finance.yahoo.com156
4. seekingalpha.com85
5. biospace.com62

Measured across the 4BusinessInsurance news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4BusinessInsurance index. Terms of use.